| Logo | Name | Σ | Employees |
|---|---|---|---|
|
Handheld Drugs of Abuse screening solutions Altiscreen is designing and manufacturing innovative, handheld drug of abuse detection devices. Our technology empowers law enforcement, healthcare providers, and other organizations to conduct rapid, accurate drug of abuse screening in the field. 59 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology |
1 | 5 |
|
Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutics to improve outcomes in conditions with unmet medical needs. Our offices and laboratory are located in San Carlos, CA. Microbial Therapeutics, Host Microbe Interactions, Human Microbiome, and Pharmaceutical Development 271 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 15 |
|
PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases. Our mission is to develop life-changing solutions for patients with diseases leading to sight loss. 85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
12 | 10 |
|
Pioneering color technology to create a safer world for all. Kinnos is a New York-based company that is pioneering color technology to revolutionize how we use disinfectants. Our flagship product, Highlight, is a patented and award-winning technology used by first responders, healthcare systems, and transit agencies to radically improve disinfection technique and quality. 32 similar entities Type: Startup Activities: biotech deeptech |
4 | 9 |
|
Experience the skin microbiome revolution! We are a skincare startup founded in 2018 in San Francisco. We combat the rise of skin conditions and sensitive skin by building a world in which beauty and science work together to produce optimal health. We develop clean, science-backed products that respect our skin’s natural ecosystem. Discover our B2B microbiome tech platform @hellobiome. Our founder, Elsa Jungman, has a Ph.D. with strong expertise in dermatology, microbiome and clean beauty. She is a UCSF, L’Oréal and AOBiome alumna. Skincare, Skin Health, Beauty, Science, Dermatology, microbiome, sensitive skin, and Biotech 89 similar entities Type: Startup Activities: deeptech healthtech Technologies: Bio sourced materials |
0 | 3 |
|
Advancing Consumer Epigenetics EpigenCare is a privately held personal epigenomics and digital biotechnology company based in New York. The company offers a direct-to-consumer epigenetics test to assess the dynamic state of one's skin type and quality. Subsequently, capture of the dynamic quality allows for actionable results from the analysis report such that optimized product options are recommended to the consumer. skincare, blockchain, epigenetics, and personal genomics 56 similar entities Type: Startup Activities: biotech deeptech Technologies: Blockchain/Cryptocurrency |
2 | 2 |
|
#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid 202 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology |
5 | 27 |
|
Rewriting the rules of drug creation Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas … 219 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology |
5 | 64 |
|
less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis 931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
2 | 10 |
|
Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration. 60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
0 | 1 |
|
ONCOMECA
Early diagnosis of skin cancers has never been that easy! ONCOMECA is a class IIb medical device according to the EU regulation 2017/745. Our technology lies in the identification of early skin cancers using their mechanical markers combined to their visual characteristics. Our expertise has been miniaturized and automatized to provide an easy-to-use and 90% reliable technology! 149 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology |
0 | 1 |
|
Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming 85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
4 | 10 |
|
Global leader in the field of plant microRNAs Mirnagreen is harnessing the power of natural MIRNA to generate super-charged applications to address and resolve the most pressing biological challenges of our time. MIRNA are small non-coding nucleic acids which exchange communication and instructions within and between organisms and are the products of millions of years of evolutionary refinement. Mirnagreen has developed the first proprietary platform for the large-scale extraction of natural MIRNA from biological sources and the development of products which make full use of their combinatorial biological efficacy. Natural MIRNA are destined to revolutionise life science applications from immune … Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials |
0 | 12 |
|
Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare 423 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology |
12 | 2 |
|
Skin care reinvented DermaWeave is Corryn Biotechnologies' world-first contactless microfibrous delivery system for use following cosmetic procedures. Using a patented handheld applicator and single-use fluid cartridge, the system forms a breathable, soluble microfibre matrix directly onto the skin, providing soothing coverage and consistent delivery of cosmeceuticals. 66 similar entities Type: Startup Activities: healthtech deeptech Technologies: New Materials |
1 | 4 |
|
Rwanda FDA's mission is to regulate medical products, processed foods, household products, and tobacco and tobacco products to ensure their quality and safety so as to protect the population of Rwanda from defective, falsified and substandard products. 59 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology |
2 | 197 |
|
Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI 267 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology |
11 | 612 |
|
The Supramolecular Chemistry Company Aqdot is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products. Aqdot’s patented AqFreshTM technology consists of cucurbiturils which have a unique structure, enabling them to capture a wide range of odour & pollutant molecules. This has the team working in areas from home and personal care, automotive, hygiene, and delivery of therapeutics for cancer. Our Purpose: Making lives better through chemistry and innovation Our Vision: The world leading supramolecular Chemtech company. Agile, exemplary in teamwork and fearless in leadership Our Mission: Scale and sell proprietary … 76 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
2 | 19 |
|
We accompany companies with a complete service of Preclinical Trials and Clinical Trials of safety and efficacy GOYA INNOVA is a Spanish laboratory with 50 years of experience, specialized in preclinical and clinical evaluations of safety and efficacy for cosmetic, health products and food supplements. We manage 55,000 samples annually, and with our partners, we offer a comprehensive service. Our differential model of preclinical and clinical research integrates a CRO with its own Medical and Medical-Aesthetic Center. With more than 40 doctors of different specialties, we can: • Carry out studies under the highest quality standards • Optimize costs and … 289 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology |
0 | 43 |
|
We believe in turning the power of plants into solutions that restore and maintain the balance in human health Phynova is a British life science company specialised in developing and commercialising unique, science proven health ingredients, powered by plants. Next to a number of pipeline ingredients, Phynova’s key ingredient is Reducose®, a patented water extract of white mulberry leaves. Through 11+ clinical studies it has been shown to promote healthy blood glucose and insulin responses and Reducose® is now being used by Dietary Supplement and F&B brands globally. Plant based compounds, Nutraceuticals, Functional ingredients, Blood Glucose Management, and Joint and … 66 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Bio sourced materials |
3 | 22 |
|
One Life One Skin Skin Tech Pharma Group SLU is specialized in high-quality manufacturing of medical devices (Class II and III), injectables and peelings as well as advanced cosmeceuticals. Founded by Dr. Philippe Deprez in 1994, the company is dedicated to innovation, developing unique formulations through its internal R&D. With more than 30 years of expertise in aesthetic medicine, Skin Tech Pharma Group has established itself as a global player in the aesthetic market, with its brands available in more than 70 countries. The company's commitment to meeting diverse market needs has driven its expansion into the pharmaceutical sector, broadening … 81 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology |
0 | 118 |
|
We develop Optimer® binders to enable innovation across the life science industry. Aptamer Group develops Optimer® binders to enable innovation in the life science industry. Get our newsletter: https://aptamergroup.com/newsletter Research and Development, Assay Development, Custom development, Drug development, Custom reagents, Agriculture testing, Aptamers, Biomarker discovery, Affinity ligands, Environmental testing, Affinity chromatography ligands, ADCs / AOCs, QC reagents, Diagnostic tools, and Targeted delivery 62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
7 | 48 |
|
Developing Breakthrough Cancer Immunotherapies Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile. Cancer Immunotherapies, Phosphatases, Immuno-Oncology, Checkpoint inhibitors, CAR-T, and Solid tumours and Lymphomas 344 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
0 | 4 |
|
Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity 512 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology |
43 | 24 |
|
Copperlife.eu
Protect your Health Copperlife is a B2B e-commerce business that deals with the promotion and marketing of copper products and technologies with the aim of protecting people's health and improving quality of life. Prevention and antimicrobial/antiviral protection, Medical devices, Nanotechnology of the frame, and Technology of the frame 159 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology |
1 | N/A |
|
New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company which aims to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic effectiveness implemented. Sirius NeoSight uses breakthrough patented technology from a consortium of academic laboratories with expertise in the field. 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
23 | 14 |
|
CLARTEIS is a global leader in manufacturing advanced and innovative technologies for the Dermatological market. CLARTEIS team is specialized in developing miniaturized and high quality light-based medical devices to provide to Dermatologists worldwide. 65 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology |
3 | 13 |
|
AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine 359 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
1 | 1 |
|
Reinventing the monitoring of patients on cancer drugs #AKOadom, Continuum+ Connect Remote Monitoring Platform Closer to patients. cancer, health, digital, E-health, Home support, and remote monitoring 218 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology |
39 | 12 |
|
Explore the Unseen BioAxial is now part of Telight. Please follow our news at Telight LinkedIn page https://linkedin.com/company/telight TELIGHT specializes in a field of instruments employing light optics, in particular, providing innovative types and solutions for light microscopy. Super Resolution Microscopy, Fluorescence Microscopy, Conical Diffraction Optical Components, Nanoscopy, Living Cell Imaging, Low phototoxicity, Standard Workflow, Multicolor Imaging, and Intuitive 87 similar entities Type: Startup Activities: nanotech deeptech Technologies: Synthetic Biology |
4 | 5 |
|
Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For … 633 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 8 |
|
CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. … 82 similar entities Type: SMB Activities: biotech deeptech healthtech cosmetics Technologies: Synthetic Biology |
12 | 2 |
|
Preclinical and R&D expertise for skin health care Syntivia is a research laboratory that creates and develops active compounds for dermatology and cosmetics in partnership with its customers. Our experts use the latest chemistry and extraction tools and techniques to create effective active compounds. We develop our own skin models and use the latest cellular/molecular biology and imaging techniques to build solid scientific dossiers demonstrating product efficacy. Syntivia est Laboratoire de rechercher qui créé et développe en partenariat avec ses clients des composés actifs pour la dermatologie et la cosmétique. Nos experts mettent en œuvre les derniers outils et techniques … 71 similar entities Type: Startup Activities: manufacturing deeptech biotech cosmetics Technologies: Synthetic Biology |
0 | 11 |
|
Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris. 60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 5 |
|
OneHealth/AI DeepTech discovering patentable mixes of natural ingredients preserving health and optimizing bioprecesses Alphanosos, a Green One-Health DeepTech company, uses its own Artificial Intelligence algorithms to discover, develop and market active ingredients and products based on blends of extracts from non-pharmaceutical ingredients, in particular edible plants. These active mixtures, some of which are already patented in 15 countries for their antimicrobial activities, are intended for the animal hygiene, dermocosmetics, food preservation and cosmetics sectors, bioprocess optimization and in the longer term, for functional foods and disease treatments. The company began its Research and Development (R&D) activities in mid-2015 and is … 224 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. |
7 | 4 |
|
DISCOVER MELA BRIGHT [C+]: THE FIRST STABLE CYSTEAMINE INNOVATIVE SKIN SCIENCE High performance treatments from our advanced research on innovative natural active ingredients. Our philosophy: protect the skin with powerful antioxidant serums and deeply correct signs of aging with premium treatments. • International scientific board specialized in R&D for innovative skin treatments • Products recommended by dermatologists, aesthetic physicians, plastic surgeons and supported by key opinion leaders. • International clinical studies • Selective distribution: pharmacies, clinics, spas, doctors and e-shop • Made in France - Worldwide development ANTI-AGING, AESTHETIC TREATMENTS, ANTIOXIDANT SERUMS, RESEARCH AND DEVELOPMENT, COSMETICS, EXPORT, INNOVATION, ANTIOXIDANT, CORRECTION, … 204 similar entities Type: Startup Activities: deeptech biotech healthtech cosmetics Technologies: Bio sourced materials |
1 | 18 |
|
Develops innovative technological systems for skin care intended for home use. Lightinderm is a French start-up hosted at Cochin Hospital in Paris, which develops innovative technological systems for skin care intended for use at home. Inspired by dermatological treatments, its multi-patented innovation combines for the first time photobiomodulation, photo-active serum capsules and tissue massages. This unique combination activates the natural regeneration of cells and visibly improves the quality of the skin. 9 years of research - 43 patents - 7 clinical studies Medical Devices and Cosmetics 75 similar entities Type: Startup Activities: deeptech healthtech manufacturing cosmetics Technologies: Synthetic Biology |
3 | 22 |
|
Bring Your Skin To Life At the forefront of innovation, we never stop to question ourselves. We push the boundaries of cosmetics and of the bio-technological industry, and we always set ourselves new challenges - those of inventing the technical solutions of tomorrow, drawing inspiration from and growing plankton, seaweeds and plants with still underestimated properties. 77 similar entities Type: SMB Activities: cosmetics deeptech Technologies: Bio sourced materials |
5 | 26 |
|
Nanoparticle-Based Radiopharmaceuticals for Targeted Radiation Delivery to Cancer Cells aKen Medical is a biotechnology company that encapsulates highly potent radioactive materials within stable nanoparticles serving as "guided missiles" that deliver targeted radiation straight to tumors while protecting healthy tissue. Our universal nanoparticle platform is designed to address a wide range of cancers, enabling real-time monitoring and advancing a theranostic approach that paves the way for precision medicine. Radiopharmaceuticals, Targeted therapy, Theranostics, Radiation Therapy, Alphatherapy, Nanotechnology, Cancer Therapy, Biotechnology, Radiotherapy, and Precision Medecine 127 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
20 | 5 |
|
We're on a mission to cure blindness with our transformational platform of advanced therapies. Aurion Biotech, Inc. (Aurion Biotech) is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care. CAUTION: New Drug—Limited by Federal (or United States) law to investigational use. 73 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 115 |
|
SPOTMYUV is your SPF’s new BFF! 💜 One sticker works all day to show you when to re-apply your sunscreen.☀️ #GetSpotted SPOTMYUV® is the world's first clinically proven UV Detection Sticker that gives you a personalized reminder of when it's time to reapply your sunscreen. As you run, swim, sweat, and play, SPOTMYUV's® patented DermatrueTM skin mimicking technology interacts with sunscreen like your skin, giving you a clear view of your sun protection in real time. Nanotechnology, Sun Care, Cosmetics, Consumer Packaged Goods, beauty, skincare, and SPF 55 similar entities Type: Startup Activities: nanotech biotech deeptech cosmetics |
4 | 1 |
|
Laboratory Testing Excellence Eurofins Biolab S.r.l. is a GMP & GLP Laboratory part of the BioPharma Product Testing Division of Eurofins Scientific. Pharmaceuticals, Medical Devices, Biocides and Cosmetics are our main areas of interest GMP, GLP, ISO 17025, ISO 9001, ISO 13485, ISO 22716, FDA INSPECTED, BioPharmaceutical Testing, Medical Device Testing, Biocide Testing, Cosmetic Testing, Professional Scientific Services, Regulatory and Consultancy, Microbiological and Chemical Testing, Training, and Laboratory Testing 244 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology |
1 | 475 |
|
A Joint Venture with Unilever PLC, creating a world free of harmful Biofilms though novel technology inspired by Nature. Were are a Joint Venture initiative with Unilever PLC formed in late 2019 with exclusive rights to the commercialise a new and novel technology based on furanone chemistry that inhibits Biofilms. Inspired by the biology of red seaweed, this single molecule platform offers a sustainable low-toxicity alternative to existing biocides. It has activity against bacteria by blocking quorum sensing and communication through multiple identified molecular targets in the bacteria, but is also effective against moulds and algae making this a unique … 63 similar entities Type: Startup Activities: deeptech biotech Technologies: Bio sourced materials |
0 | 8 |
|
Advanced Nanotechnologies A nanobiotechnology and smart polymers company. The company is committed to products for several engineering the biomedical sectors, with an emphasis on tissue engineering, drug delivery and functionalized electrospun nanofibers. Nanofaber Srl is the exclusive distributor on the Italian soil of Bioinicia Fluidnatek Slu, leader company in Europe regarding the electrospinning equipment and services. Through its high-specialized division, Nanofaber can offer to its clients premium equipment, services and commercial/technical assistance on the electrospinning and electrospraying technology. nanofibers, SERS, oncoproteins, and nanomechanics 58 similar entities Type: Startup Activities: nanotech deeptech Technologies: Synthetic Biology |
6 | 10 |
|
Follow us at Shionogi Inc. for news about our rare disease research programs https://www.linkedin.com/company/shionogi-inc-/ drug discovery, PDE4D, PDE4B, Fragile X, CTE, Rubinstein-Taybi, traumatic brain injury, Clinical Trials, Fragile X syndrome, Cognition, BPN14770, and Memory Loss 364 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 5 |
|
Evolution. Adaptation. Future. Phage-based solutions to combat bacteria. - Prevention - Diagnosis - Treatment "One Health" personalized treatments. biotecnología, microbiología, investigación, biomedicina, bacteria, phage, and phage therapy 185 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology |
2 | 6 |
|
RhyGaze is pioneering a transformative approach with cone optogenetics, which has the potential to revolutionize vision restoration for patients suffering from blindness. pharmaceutical development, optogenetics, gene therapy, ophthalmology, and pharmaceutical research 117 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
0 | 17 |
|
Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, … 69 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology |
0 | 4 |
|
Innovation in Skin Health Skinosive is a science-driven dermo-cosmetics biotechnology company developing a technology platform in skin photoprotection. Skinosive’s technology enables long-acting skin UV protections and effective sunscreens that prevent chemicals from being absorbed into the skin and the bloodstream. This innovation aims to reduce drastically cancer and skin damages due to the sun exposure. The company is located in Paris and in Marseille. Skinosive Headquarter : 12-14 rue Jean Antoine de Baïf 75013 Paris Skinosive Lab : 60 avenue André Roussin 13016 Marseille 52 similar entities Type: Startup Activities: deeptech biotech Technologies: SaaS |
7 | 12 |
|
Revolutionary Science, Biological Wisdom. For every giant leap in technology, the human body remains our most remarkable machine: this belief has led Professor Augustinus Bader, one of the foremost scientists of his generation, to unlock the body's healing code. His breakthrough medical treatment activates and orchestrates the body's own stem cells to repair and regenerate. From skincare to clinical practice to biotech research, all our advances are grounded in a belief that the body is its own best therapist. 56 similar entities Type: Startup Activities: cosmetics Technologies: Synthetic Biology |
1 | 239 |
|
Santizes Protects Illuminates Biovitae is the first patented multi-wavelengths LED no UV microbicide technology. It eliminates bacteria, viruses, moulds, fungi and spores. Only with Biovitae it is possible to guarantee the continuous sanitisation of rooms because it perfectly integrates the sanitisation function with the lighting function, guaranteeing natural white light that is totally safe for humans and animals. We want to propose innovative solutions for a better life, and we are committed to promoting innovation in the health and well-being of living beings and the environment in which they live. Biovitae is the ambitious fruit of our efforts. Biotechnology, Energy, … 84 similar entities Type: Startup Activities: deeptech Technologies: Bio sourced materials |
1 | 11 |
|
Life science company focused on skin health. Development of Pro- and Post-biotic ingredients from true skin commensals. S-Biomedic is a life science company focused on skin health by pioneering the development of Pro- and Post-biotic ingredients from true skin commensals. S-Biomedic delivers: • novel active ingredients for use in cosmetic formulations • unique positioning & skin benefits • clinically substantiated efficacy claims S-Biomedic is changing the paradigm in skincare and dermatology by unleashing the natural power of your skin microbiome capitalizing on its breakthrough proprietary technology platform and expertise to deliver novel solutions for a wide variety of skin conditions. … 58 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials |
4 | 21 |
|
ATOXIGEN is your partner in early R&D. We offer a variety of standardized or customized assays based on the latest innovations in the fields of cellular biology, molecular biology and genomics. Innovative predictive efficacy assays on reconstructed epidermis or primary cell lines from human explants (proteasome, autophagy, detoxification, anti-ageing...); in vitro genotoxicity testing (micronucleus and chromosome aberration tests); endocrine disruptor screening; customized services. Biotechnologies, Testing & Research, Evaluation toxicologique, and Assurance qualité 211 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
3 | 3 |
|
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics an @Ipsen company designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. antibodies, immuno-oncology, Immune checkpoint Modulators, Auto-immunity, innate immunity, oncology, cancer, precision-based medicine, adaptative immunity, EVICTIONtrial, ICT01, and gamma-deltaTcells 246 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
43 | 45 |
|
Your partner for in vitro and ex vivo studies We aim to maximize the efficiency of our clients’ in vitro and ex vivo studies and tests, by offering services with innovative equipments and protocols and optimizing their research process on human skin samples. To help you achieve your expectations, we provide innovative equipments, on demand skin samples, tests & studies Diffusion Test, Franz Cells, Microdialysis, Glasbox®, Fibroblast Tension studies, Human Skin Sample, Permeation Test, Cosmetic assay, Dermatology, Efficacy testing, Ex vivo Tests, CRO, Epidermis/dermis studies, Skin Research, Skin Test, Skin model, invitro exvivo tests, and skin microbiota Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
1 | 4 |
|
Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP 209 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
2 | 34 |
|
New Technologies for a New Skin Ojer Pharma es una compañía farmacéutica, spin-off de la Universidad de Navarra, que nace al amparo del Centro de Investigación en Farmacobiología Aplicada (CIFA), el Instituto Científico y Tecnológico de Navarra (ICT) y la Fundación Universitaria de Navarra (FUNA) con el objetivo de desarrollar medicamentos y productos dermatológicos innovadores que satisfagan las necesidades de los pacientes a nivel internacional. Ojer Pharma dirige todos sus esfuerzos a investigar y desarrollar productos que aborden las patologías dermatológicas desde una perspectiva global: tratamiento conjunto de causas y síntomas. El objetivo último de la compañía es convertirse en … 57 similar entities Type: SMB Activities: biotech deeptech |
0 | 24 |
|
Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue 71 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology |
8 | 9 |
|
Changing the future of Oncology Sutro Biopharma, Inc., is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro is advancing a robust early-stage pipeline of novel exatecan and dual-payload antibody drug conjugates (ADCs), coupled with high-value collaborations and industry partnerships, which validate its continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com. 59 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology |
10 | 198 |
|
Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune 565 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
11 | 3 |
|
Pranarôm, Pioneer in Scientific Aromatherapy for 30 years. World reference in Scientific Aromatherapy for 30 years, Pranarôm is the expert in natural and effective solutions developed from 100% pure, integral and organic chemotyped essential oils. Essential supplements or substitutes for drug treatments, Pranarôm synergies offer targeted responses in all areas of health and adapted for the whole family. Essential oils, aromatherapy, aromatherapie, santénaturelle, Vegetal oils, and naturalhealth 46 similar entities Type: SMB Activities: deeptech foodtech healthtech Technologies: Synthetic Biology |
4 | 183 |
|
Ocular supplements crafted with you in mind. 🔬 At MacuHealth, we are dedicated to leading the nutritional supplement industry through innovation. Our premium products are formulated with pure and stable ingredients that support eye health through your nutritional journey. Experience the difference with MacuHealth – Nutrition You Can See. Eye Supplement, Eye Vitamin, and EyeWellness 59 similar entities Type: SMB Activities: deeptech healthtech Technologies: Bio sourced materials |
0 | 49 |
|
Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free 83 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology |
15 | 970 |
|
LSC Technologies
The light beautifies your skin LSC Technologies is a start-up project led by 5 students from the Institut d'Optique Graduate School in collaboration with 2 researchers from the Charles-Fabry laboratory. Our technology: luminescent concentrators We rely on luminescent concentrator technology, which allows precise control of light. 3 patents protect this technology, developed in the Charles-Fabry laboratories. Our product: SkinLight The SkinLight product incorporates luminescent concentrator technology to enhance light sources used in dermatology, for applications ranging from the treatment of skin cancer and acne to permanent hair removal. By improving the classic pulsed light machines on which it is implemented, … 50 similar entities Type: Startup Activities: deeptech |
3 | 1 |
|
Advancing chemistry. Enhancing health. Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential. Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem (located in France) is the recipient of multiple French scientific awards and European Union and French government grants. Sirona Biochem is a publicly-traded company. The company is listed on the TSX Venture Exchange in Canada … 57 similar entities Type: SMB Activities: deeptech cosmetics Technologies: Synthetic Biology |
5 | 4 |
|
Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library 297 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology |
0 | 9 |
|
Captor Therapeutics is a publicly-listed (WSE:CTX) innovative drug discovery and development company focused on targeting the undruggable proteome using targeted protein degradation. Our mission is to transform lives of patients suffering from cancer, autoimmunity and neurodegenerative diseases. Our groundbreaking technology is perfectly suited to create new drug candidates with the potential to ease patients' burden and cure conditions that so far have only been poorly treatable. Captor Therapeutics S.A. implements projects co-financed by the European Union. All information about the projects is available at: https://captortherapeutics.com/grant-projects. drug development, biotechnology, and protein degradation 734 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
0 | 84 |
|
We harness the power of biology to create revolutionary live-active cell-based products and solutions. NanoSpun is a global pioneer and frontrunner in the biotech, advanced materials and bioprinting spaces. We are leading the way to a whole new generation of cell-based products and solutions through the intelligent application of NanoSpun biological fabrics. No other company can do what we do. We encapsulate live and active biological cells and organisms, including bacteria, yeast, algae, plant cells, and mammalian to produce living tissues and fabrics with a wide application across many industries. Our current market focus is to revolutionize Skincare and Bioprocessing. … 56 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
0 | 10 |
|
No miracles, just science® PhD Trials is an experienced International CRO that performs clinical assessment of safety and efficacy of cosmetics, food supplements and raw material products for the cosmetic industry (HRIPT, Patch test, Open Test studies, all the efficacy studies and other special projects). Cosmetic trials, Efficacy studies, Safety studies, In vivo, and Raw materials 86 similar entities Type: Startup Activities: cosmetics deeptech biotech Technologies: New Materials |
0 | 52 |
|
Transforming millions of people's skin through patented, 40x award-winning light therapy tools & topicals A Los Angeles, California-based skincare brand dedicated to developing innovative and efficient skincare tools and topicals for all genders, ethnicities, and skin tones. 69 similar entities Type: Startup Activities: cosmetics healthtech deeptech |
3 | 27 |
|
Miniproteins TM Activen - a Remora Venture - is a Swiss biotech company dedicated to the discovery and the marketing of natural miniproteins as a new class of cosmetic actives. Cosmetics, XEP-018, Miniproteins, XEP-716, and Dermo-cosmetic 72 similar entities Type: Startup Activities: deeptech cosmetics Technologies: Bio sourced materials |
5 | 10 |
|
AFFICHEM
Posterem is a medicinal chemistry company that develops innovative molecules for therapeutic purposes against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Posterm is a medicinal chemistry company which develops innovative therapeutic molecules against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. 64 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 1 |
|
Pioneering therapies based on aptamer technology aptaTargets is a clinical stage biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. Our candidates are neuroprotectants and immunomodulators being developed from preclinical stages up to clinical proof-of-concept. Biopharmaceutical, Biotechnology, Aptamers, Immunology, Stroke, and Inflammatory diseases 390 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
4 | 10 |
|
Mallia develops cosmetic applications for hair growth and biopharmaceutical therapies for hair loss. Mallia Innovations GmbH is the holding company strategically driving the development and commercialization of cosmetic applications and biopharmaceutical therapies of the immune modulatory sCD83 protein, targeting hair growth, hair loss and other dermatological indications, including wound healing. Subsidiary Mallia Aesthetics GmbH focuses on the development of cosmetic products to stimulate hair growth. Subsidiary Mallia Therapeutics GmbH focuses on the clinical development of novel therapies for patients suffering from androgenetic alopecia or alopecia areata, among other conditions. 54 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
1 | 16 |
|
Natural Innovation for a Better Life. Applying the real power of plants to cosmetics through biotechnology We create natural active ingredients for skincare and haircare through innovative and sustainable biotechnology processes which obtain the real power of plants. Totipotent Cells 87 similar entities Type: Startup Activities: deeptech cosmetics biotech Technologies: Bio sourced materials Synthetic Biology |
2 | 45 |
|
Trusted chemicals, laboratory products and supplies since 1971. Spectrum Chemical Mfg. Corp. manufactures and distributes fine chemicals and laboratory products with quality and delivery you can count on every time. The Company’s major emphasis is on USP, NF, FCC, BP, EP, JP and ACS grade products, active pharmaceutical ingredients and controlled substances, excipients, dietary supplements, cosmetic ingredients, biochemicals, pre-made solutions, and a complete line of high-purity solvents for critical analytical applications. These products are available in laboratory research, scale-up and production quantities. Spectrum also provides US-based custom synthesis and contract manufacturing capabilities, including the custom synthesis of new chemical entities … 53 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Bio sourced materials |
1 | 234 |
|
Addressing structural limitations beneath the skin Aliform is a VC-backed, clinical-stage medical device startup company developing new devices to make skin surgery safer, easier, and more accessible. Celluleaf®, our first product, is a minimally invasive tool designed to release fibrous septae under the skin while respecting surrounding tissue structures. 83 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology |
0 | 13 |
|
Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology 616 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
0 | 3 |
|
To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies 630 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
1 | 9 |
|
We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work 310 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
11 | 14 |
|
Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening 514 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
4 | 789 |
|
Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is ColdZyme®, a mouth spray which protects against common cold, can help shorten the duration of a common cold if used at an early stage of the infection, alleviates common cold symptoms and soothes sore throat. Our head office is in Lund, Sweden, but we also have an office in Reykjavik, Iceland. For product info, please visit at www.coldzyme.co.uk. Cold and Flu, Enzyme (trypsin), and Barrier technology 219 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology |
0 | 26 |
|
Light Activated Therapeutics Lightox has developed a new drug for the treatment of early stage oral cancers. The topically applied formulation allows for specific delivery to the lesion and is activated by a specific wavelength of light. 67 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
1 | 20 |
|
Visionary Care Since 1935 always committed to improve patients’ quality of vision. SIFI is expanding into international market providing innovative solutions for ocular diseases. Eye Care, Pharmaceutical/Nutraceuticals/Medical Devices, Surgical & Diagnostic Medical Devices., Ophthalmology , Science, Researchers , Research, Vision, Eyes, Surgical, Medical technology, Health, Medicine , Eye health , and Biotech 90 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology |
2 | 626 |
|
The goal of Tetrahedron is to help maintain or restore a healthy life by designing and developing new active ingredients for cosmeceutical, nutritional, biomedical and therapeutical applications. These ingredients may be natural compounds, for which Tetrahedron develops new and sustainable synthesis processes allowing an industrial production of these compounds, or novel molecules derived from natural compounds, therefore providing proprietary compounds. Oxidative stress, Free radical biology, Antioxidant, Sulfur and selenium chemistry, Process development, Ergothioneine, Green chemistry, Sustainable chemistry, and Rare sulfur-containing amino acids 68 similar entities Type: SMB Activities: manufacturing biotech deeptech Technologies: Synthetic Biology |
0 | 3 |
|
HARNESSING NATURE FOR PEOPLE AND THE PLANET Octarine Bio is a Copenhagen-based company pioneering a new generation of sustainable, bio-based colourants produced via precision fermentation. We engineer nature inspired colours that deliver the performance, stability, and safety profile required for demanding industrial applications while decoupling colour from fossil based chemistry. Our PurePaletteTM portfolio offers bio-based colourants for use on textiles, plastics, packaging, and other materials. Designed for drop-in integration, PurePaletteTM targets price parity with conventional colourants in key use cases, enabling customers to adopt more sustainable solutions without compromising on cost, quality, or scalability. Synthetic Biology, Fermentation, Yeast metabolism, Plant … 56 similar entities Type: Startup Activities: cleantech deeptech greentech Technologies: Synthetic Biology |
8 | 29 |
|
Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development 248 similar entities Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology |
5 | 44 |
|
UV-C High-Level Disinfection for endocavitary and external ultrasound probes Germitec’s mission is to protect patients, healthcare professionals and prevent infections with innovative UV-C High Level Disinfection devices. Our products uses patented Yuvee® UV-C technology to provide High-Level Disinfection (HLD) for endocavitary and external ultrasound probes. ultrasound, disinfection, highleveldisinfection, infectioncontrol, ultraviolet, UVC, HLD, transducers, HPV, hightech, medtech, greentech, cleantech, frenchtech, healthtech, innovation, patientsafety, and infectionprevention 64 similar entities Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology |
16 | 66 |
|
Secuderm, revolutionary skin protection technology: validated by Navy doctors on swimmers in immersion, now makes it possible to secure a treatment or a device and free the patient Secuderm, unique and revolutionary technology which secures a care (device, cream..) and frees the patient. 59 similar entities Type: SMB Activities: deeptech healthtech |
6 | 3 |
|
Transforming lives with groundbreaking treatments Coultreon Biopharma's mission (formerly Onco3R Therapeutics) is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs. The team is leveraging their knowledge and expertise to bring transformative innovations to patients suffering from auto-immune diseases. In this field, there is an urgent need for more convenient oral drugs that can offer greater efficacy with a better safety profile. Drug Discovery, Drug Development, Immunology, Biotech, and R&D 826 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 32 |
|
We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Sign up for our quarterly newsletter to keep up with our progress: https://lnkd.in/eCH3d6ay 153 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
3 | 47 |
|
Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry 535 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
0 | 21 |
|
a wholly owned subsidiary of Eli Lilly and Company LimmaTech Biologics AG, a wholly owned subsidiary of Eli Lilly and Company, is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. vaccines, research & development, biotechnology, and antimicrobial resistance 419 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
1 | 57 |
|
Une entreprise spécialisée dans le développement de thérapies transformatrices ayant un impact sur la longévité. Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging. Our small molecules are aimed at stimulating biological resilience to stress during aging. Ruvembri - in regulatory and clinical phases - is our leading drug candidate is administered orally: • for the treatment of severe respiratory events related to COVID-19 following positive results in Phase 2/3 clinical study (COVA) • for the treatment of reduced mobility in elderly patients with sarcopenia, … 263 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
6 | 24 |
|
Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development 428 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 12 |
|
We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine. science+art, biotech, mRNA, IPF, Pulmonary fibrosis, and delivery 561 similar entities Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology |
9 | 9 |
|
Destroying cancer at the speed of light Theralase® Technologies is a Canadian clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers. We strive to continuously improve the quality of life for those afflicted with cancer by focusing our research and development on preventing, alleviating and treating diseases. Serving our higher purpose to bring hope for cancer treatments to light. Founded in 1994, Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the … 70 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology |
1 | 34 |
|
Committed for 25 years to human dermatology, effective and accessible throughout the world. #HumanFirstDermatology Specialist in dermatology, the French and independent ACM dermatological laboratory develops and markets medicines, cosmetic products, food supplements as well as medical devices offering innovative solutions for the most common reasons for consultation. In close collaboration with the world of dermatology, we have initiated numerous research projects which have resulted in the filing of several patents and allow us to accurately provide targeted and effective responses in order to restore healthy skin and healthy hair. Dermatology, Dermocosmetics, Made In France, and Pharmacy 82 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology |
2 | 161 |
|
Novel small-molecule drugs in immunology, fibrosis and women health Clinical-stage biotech company founded by serial entrepreneurs and owned by private & institutional investors. Discovery and development of new chemical entities with strong IP and worldwide rights targeting indications with high unmet medical need in immunology, fibrosis and women health. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, Inflammation and autoimmune diseases, IP generation, IBD, Ulcerative Colitis, Crohn's disease, Fibrosis, and Uterine fibroids 346 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
0 | 8 |
|
🌿 Green nanoparticles for laser-based therapy Torskal is an early clinical-stage French biotech company specializing in green nanomedicine and laser-based therapies. The company develops eco-friendly gold nanoparticles produced through sustainable synthesis technologies for applications in oncology and women’s health. Its pipeline includes three lead programs: NT1 for skin cancer, NT2 for gastrointestinal (GI) cancers, and NT3 for endometriosis, leveraging nanoparticle-mediated laser therapy approaches Nanotechnology, Nanomedicine, Biotechnology, Nanotheranostics, Nanoparticles, Gold Nanoparticles, Cancer Research, Green Nanotechnology, and laser 82 similar entities Type: Startup Activities: nanotech biotech deeptech Technologies: Synthetic Biology |
16 | 4 |